miniPCR bio

miniPCR bio

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.8M

Overview

miniPCR bio is a U.S.-based biotechnology tools company founded in 2013 with a mission to democratize access to molecular biology. The company develops and sells a suite of compact, low-cost, and user-friendly hardware, software, and curriculum for PCR, gel electrophoresis, and fluorescence visualization, primarily targeting the educational market (K-12 and undergraduate) and field research. By lowering the cost and complexity barriers, miniPCR bio has established itself as a key player in the hands-on science education and portable diagnostics equipment space.

Diagnostics

Technology Platform

Integrated ecosystem of portable, low-cost molecular biology hardware (thermal cyclers, electrophoresis, visualization), software (miniPCR Digital), and curriculum (Learning Labs) designed for accessibility and education.

Funding History

3
Total raised:$2.8M
Series A$2.5M
Grant$250K
SeedUndisclosed

Opportunities

Significant growth potential in the global STEM education market, driven by demand for hands-on learning and budget-friendly equipment.
Secondary opportunities exist in field research, citizen science, and low-resource lab settings, leveraging the portability and affordability of the tools.

Risk Factors

Heavy dependence on education sector funding cycles and policies.
Increasing competition from other low-cost instrument manufacturers and large scientific companies entering the educational space.
Maintaining product quality and innovation while competing on low cost.

Competitive Landscape

Operates in a niche but growing segment of low-cost, portable biotech tools for education. Competes against traditional benchtop equipment manufacturers (e.g., Bio-Rad, Thermo Fisher) in education divisions, other specialized educational suppliers (e.g., Edvotek), and a new generation of startups focused on frugal science and DIY biology.